Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
about
Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosisAlzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's diseaseDisease-related and genetic correlates of psychotic symptoms in Parkinson's disease.Behavioral effects of levodopa.Changes of retina are not involved in the genesis of visual hallucinations in Parkinson's disease.Cerebral correlates of psychotic syndromes in neurodegenerative diseasesREM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease.REM sleep behavior disorder: motor manifestations and pathophysiology.Visual hallucinations in Parkinson's disease: theoretical models.Rational drug discovery design approaches for treating Parkinson's disease.Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.The role of neurotransmitters in the development of Parkinson's disease-related psychosis.Pareidolias in REM Sleep Behavior Disorder: A Possible Predictive Marker of Lewy Body Diseases?What Is the Link Between Hallucinations, Dreams, and Hypnagogic-Hypnopompic Experiences?Retrospective Neuropsychological Profile of Patients With Parkinson Disease Prior to Developing Visual Hallucinations.Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease.Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.Visual symptoms in Parkinson's disease and Parkinson's disease dementia.Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging.Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients.Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study.Inventory of real world data sources in Parkinson's disease.Risk factors for visual hallucinations in patients with Parkinson's disease.Dysfunction in attentional processing in patients with Parkinson's disease and visual hallucinations.Visual misperceptions and hallucinations in Parkinson's disease: dysfunction of attentional control networks?Fatigue is associated with the onset of hallucinations in patients with Parkinson's disease: A 3-year prospective study.Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years.Parkinson's disease psychosis: presentation, diagnosis and management.Comparison of nocturnal symptoms in advanced Parkinson's disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations
P2860
Q28074468-64B6BA9D-D5AA-4311-BB62-32C1D885240AQ34080479-C705E0CA-3E30-4C36-A8FF-50AA360B9F1CQ34438073-C6E1C3DE-E6B0-47C2-A95D-035E450F4FBEQ34452922-E949FB7C-2664-4905-90AA-E5E0AACD7B73Q35097665-5E3CFFCB-4252-413B-B2CA-F013FA41EA19Q35194993-895DC4F0-1BE2-42AD-A1DF-8E5DB79ED518Q37716114-82B4B663-55E7-4D60-AD37-3D407454098CQ37996946-439900EE-EBE3-4780-BEEB-A76A6F8030ECQ38243013-813B1E43-A93B-48A3-9DE9-035B81A3D65DQ38520864-700FD584-7A97-4DFC-A9B4-D8685C9DCB96Q38643289-08020270-9EE4-4615-AE05-5D2AC3F66392Q38649501-76EEF19E-941D-43E5-A780-EC1366815E7DQ38736816-82DBE37C-0377-4E5F-BEBB-57FCB1B14B19Q38881355-430B7E55-93C1-4831-9B53-3DDD2ABBA25AQ39032421-C5174ECF-AF6F-44F1-8D0C-5BD3D8FCA755Q39393248-5135ECDB-4EE7-4737-94C1-190C8D27E9AEQ39446817-294E1724-AF1A-44F6-8A2C-88026985A013Q39703424-B5C4EBCA-BCC3-449F-ABA6-343AC66684E9Q40499334-EB7EA653-65F1-48D4-8070-4D94134B1BE0Q42108095-5500E4FE-829B-40CD-89D8-E976FC0A0FECQ43725039-E48D363D-8D99-41B6-B50B-652193207A3AQ44498086-4196A0DE-27A3-47C3-B4D7-A17185964B55Q44956018-5BD09306-C088-4BA7-88E4-82D773D3876DQ47101523-F7796431-A782-47C6-9E24-0C2393F4F66AQ48095437-DE961EAF-2920-4BB3-AC88-6037F04C4593Q48861698-0329653B-95A7-4BF3-97B5-7AF134F4AB89Q48875242-D6BAA57A-DDFD-4764-B9BA-B62A19D1749DQ50072359-9726450E-2523-4965-B025-EF1ACF320DBFQ50794319-20ABE55D-E2B8-4902-B3FB-956ECF387586Q51781286-6E552DA7-9DFB-47F3-BF14-55121DF64F55Q57177169-F03888FE-6D9D-4EE8-81A2-3BD69F8ADF91
P2860
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
@ast
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
@en
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
@nl
type
label
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
@ast
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
@en
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
@nl
prefLabel
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
@ast
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
@en
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
@nl
P2093
P2860
P1433
P1476
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
@en
P2093
Alice Negron
Bichun Ouyang
Glenn T Stebbins
P2860
P304
P356
10.1212/WNL.0B013E3181FD6158
P407
P577
2010-10-20T00:00:00Z